A Clinically-Compatible Workflow for Computer-Aided Assessment of Brain Disease Activity in Multiple Sclerosis Patients

Over the last 10 years, the number of approved disease modifying drugs acting on the focal inflammatory process in Multiple Sclerosis (MS) has increased from 3 to 10. This wide choice offers the opportunity of a personalized medicine with the objective of no clinical and radiological activity for ea...

Descripción completa

Detalles Bibliográficos
Autores principales: Combès, Benoit, Kerbrat, Anne, Pasquier, Guillaume, Commowick, Olivier, Le Bon, Brandon, Galassi, Francesca, L'Hostis, Philippe, El Graoui, Nora, Chouteau, Raphael, Cordonnier, Emmanuel, Edan, Gilles, Ferré, Jean-Christophe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8595265/
https://www.ncbi.nlm.nih.gov/pubmed/34805206
http://dx.doi.org/10.3389/fmed.2021.740248

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8595265/
https://www.ncbi.nlm.nih.gov/pubmed/34805206
http://dx.doi.org/10.3389/fmed.2021.740248

Ejemplares similares